Whitepaper
Market Research
Immunotherapy has emerged as a promising treatment for cancer, with immune checkpoint inhibitors (ICIs) dominating the market. The market is projected to grow due to the rise in the prevalence of diseases, the increase in the adoption of combination therapies, the surge in the funding for new therapies, and the approval of innovative therapies. Numerous opportunities within the realm of immune therapies exist, considering the increasing prevalence of several diseases. Moreover, there is a notable upswing in funding for developing innovative therapies and a rising trend in novel immunotherapies approval.
To know more...
